Evidem Consultores SL Report issue

For profit
Founded: Spain (2001)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2015
NCT03222765
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Evidem Consultores SL

Active Ingredients

Drugs in Other Trials (2)

linagliptin (tradjenta) (1 trial)

metformin (glucophage) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2